APOE and COVID-19: Given the data from Kuo et al. illustrating a strong association between severe COVID-19 cases and APOE ε4ε4 genotype independent of the comorbidities, it is plausible that APOE modulates COVID-19 disease severity by regulating pro-inflammatory pathways in a genotype dependent manner.